An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease is a research paper published in Viruses (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of Arizona R Ken Coit College of Pharmacy faculty startup fund
Grant: AI175435
University of Arizona R Ken Coit College of Pharmacy faculty startup fund
Grant: AI161845
University of Arizona R Ken Coit College of Pharmacy faculty startup fund
Grant: AI131669
University of Arizona R Ken Coit College of Pharmacy faculty startup fund
Grant: AI140726
NIAID NIH HHS
Grant: R01 AI131669
NIAID NIH HHS
Grant: R01 AI140726
NIAID NIH HHS
Grant: R01 AI175435
National Institute of Allergy and Infectious Diseases
Grant: AI175435, AI161845, AI131669 and AI140726
NIH HHS
Grant: S10 OD034384
NIEHS NIH HHS
Grant: P30 ES006694
NIAID NIH HHS
Grant: R01 AI161845
National Institutes of Health
Grant: 1R01AI175435-01
Development of Inhibitors Targeting Flavivirus Methyltransferase
National Institutes of Health
Grant: 5R01AI140726-02
High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungi
National Institutes of Health
Grant: 5R01AI131669-05
High throughput screening of orthosteric inhibitors of flavivirus protease
National Institutes of Health
Grant: 5R01AI161845-02
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals